Jennifer Buell Agenus Inc (AGEN) insider trading activity

AGEN Quotes by TradingView

Jennifer Buell is of AGENUS INC. Currently has a direct ownership of 19,738 shares of AGEN, which is worth approximately $329,427. The most recent transaction as insider was on May 02, 2025, when has been sold 581 shares (Common Stock) at a price of $3.11 per share, resulting in proceeds of $1,806. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 19.7K
7.93% 3M change
84.47% 12M change
Total Value Held $329,427

Jennifer Buell Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 02 2025
BUY
Grant, award, or other acquisition
$1,806 $3.11 p/Share
581 Added 2.86%
19,738 Common Stock
Apr 18 2025
BUY
Grant, award, or other acquisition
$1,807 $2.08 p/Share
869 Added 4.34%
19,157 Common Stock
Apr 04 2025
BUY
Grant, award, or other acquisition
$1,808 $1.56 p/Share
1,159 Added 5.96%
18,288 Common Stock
Mar 21 2025
BUY
Grant, award, or other acquisition
$1,808 $1.61 p/Share
1,123 Added 6.15%
17,129 Common Stock
Mar 07 2025
BUY
Grant, award, or other acquisition
$961 $2.35 p/Share
409 Added 2.55%
15,646 Common Stock
Feb 21 2025
BUY
Grant, award, or other acquisition
$1,809 $3.32 p/Share
545 Added 3.45%
15,237 Common Stock
Feb 21 2025
BUY
Grant, award, or other acquisition
$2,078 $3.32 p/Share
626 Added 3.93%
15,318 Common Stock
Feb 07 2025
BUY
Grant, award, or other acquisition
$1,806 $3.5 p/Share
516 Added 3.39%
14,692 Common Stock
Jan 24 2025
SELL
Payment of exercise price or tax liability
$963 $3.57 p/Share
270 Reduced 1.87%
14,176 Common Stock
Jan 24 2025
BUY
Grant, award, or other acquisition
$2,770 $3.57 p/Share
776 Added 5.1%
14,446 Common Stock
Jun 30 2021
BUY
Grant, award, or other acquisition
$58,178 $5.49 p/Share
10,597 Added 7.7%
127,091 Common Stock
Apr 02 2021
BUY
Grant, award, or other acquisition
$232,005 $2.87 p/Share
80,838 Added 40.97%
116,494 Common Stock

Also insider at

INKT
MiNK Therapeutics, Inc. Healthcare
Chief Executive Officer
PTIXW
Protagenic Therapeutics, Inc.new ETFs
Director
JB

Jennifer Buell

Lexington, MA

Track Institutional and Insider Activities on AGEN

Follow AGENUS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AGEN shares.

Notify only if

Insider Trading

Get notified when an Agenus Inc insider buys or sells AGEN shares.

Notify only if

News

Receive news related to AGENUS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AGEN